← SynDRA
PIMOZIDE
SynDRA canonical compound SYN0006402 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR2A |
|---|
| Mechanism of action | Dopamine receptor antagonist |
|---|
| Indication | Tourette's disorder |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- DRD2
- DRD3
- HTR2A
- CACNA1I
- HTR1A
- DRD4
- KCNA10
- HRH1
- CACNA1H
- DRD5
- KCNH2
- DRD1
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- DRD2 ANTAGONIST
- DRD3 ANTAGONIST
- DRD5 ANTAGONIST
- DRD4 ANTAGONIST
- DRD1 ANTAGONIST
- HTR1A ANTAGONIST
- CACNA1H PORE BLOCKER
- CACNA1I ANTAGONIST
- HRH1 ANTAGONIST
Drug classes
- Anti-Dyskinesia Agents
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Dopamine Agents
- Dopamine Antagonists
- Neurotransmitter Agents
- Psychotropic Drugs
- Tranquilizing Agents
- Typical Antipsychotic
ATC classes
Cross-references
Synonyms
- primozide
- R6238
- R-6238
- Pimozida
- MCN-JR-6238
- NSC-170984
- R-623
- Orap
- Antalon
- Neoperidole
- Opiran
- Pimozidum
- Primozida
- ASTA Medica Brand of Pimozide
- Janssen Brand of Pimozide;Orap forte
- Pharmascience Brand of Pimozide
- P 1793
- McN-JR-6238
- Orap (TN)
- Pimozida [INN-Spanish]
- Pimozidum [INN-Latin]
- Primozida [INN-Spanish]
- Pimozide (JAN/USP/INN)
- Pimozide [USAN:INN:BAN:JAN]
- 1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone
- 1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine
- 1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one
- 1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone
- 1-[4,4-Bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine
- 1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
- 1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one
- 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one
- R 6238
- pimozide (ep monograph)
- pimozide (usp-rs)
- McN-JR 6238
- pimozide (usp monograph)
- NSC 170984
Reported adverse events
- Akathisia
- Akinesia
- Asthenia
- Constipation
- Depression
- Dizziness
- Dyskinesia
- Dysphagia
- Eructation
- Headache
- Hyperkinesia
- Hyperpyrexia
Look up PIMOZIDE in the interactive SynDRA portal →